Company Z-prime's earnings and dividends per share are expected to grow oy 4% a year. Its growth will stop after year 4. In year 5 and afterward, it will pay out all earnings as dividends. Assume next year's dividend is $2, the co of equity is 12%, and next year's EPS is $9. What is Z-prime's stock price? Note: Do not round intermediate calculations. Round your answer to 2 decimal places. X Answer is complete but not entirely correct. Stock price $ 58.91

Intermediate Financial Management (MindTap Course List)
13th Edition
ISBN:9781337395083
Author:Eugene F. Brigham, Phillip R. Daves
Publisher:Eugene F. Brigham, Phillip R. Daves
Chapter8: Basic Stock Valuation
Section: Chapter Questions
Problem 5P: A company currently pays a dividend of $2 per share (D0 = $2). It is estimated that the company’s...
icon
Related questions
icon
Concept explainers
Topic Video
Question
Company Z-prime's earnings and dividends per share are expected to grow
by 4% a year. Its growth will stop after year 4. In year 5 and afterward, it will
pay out all earnings as dividends. Assume next year's dividend is $2, the cost
of equity is 12%, and next year's EPS is $9. What is Z-prime's stock price?
Note: Do not round intermediate calculations. Round your answer to 2
decimal places.
X Answer is complete but not entirely correct.
Stock price
$
58.91 X
Transcribed Image Text:Company Z-prime's earnings and dividends per share are expected to grow by 4% a year. Its growth will stop after year 4. In year 5 and afterward, it will pay out all earnings as dividends. Assume next year's dividend is $2, the cost of equity is 12%, and next year's EPS is $9. What is Z-prime's stock price? Note: Do not round intermediate calculations. Round your answer to 2 decimal places. X Answer is complete but not entirely correct. Stock price $ 58.91 X
Problem 4-10 Constant-growth DCF model
Pharmecology just paid an annual dividend of $1.55 per share. It's a mature
company, but future EPS and dividends are expected to grow with inflation,
which is forecasted at 3.75% per year. The nominal cost of capital is 10.50%.
a. What is Pharmecology's current stock price?
Note: Do not round intermediate calculations. Round your answer to
2 decimal places.
b. What would be Pharmecology's current stock price using forecasted
real dividends and a real discount rate?
Note: Do not round intermediate calculations. Round your answer to
2 decimal places.
a. Current stock price
b. Current stock price
$
23.82
Transcribed Image Text:Problem 4-10 Constant-growth DCF model Pharmecology just paid an annual dividend of $1.55 per share. It's a mature company, but future EPS and dividends are expected to grow with inflation, which is forecasted at 3.75% per year. The nominal cost of capital is 10.50%. a. What is Pharmecology's current stock price? Note: Do not round intermediate calculations. Round your answer to 2 decimal places. b. What would be Pharmecology's current stock price using forecasted real dividends and a real discount rate? Note: Do not round intermediate calculations. Round your answer to 2 decimal places. a. Current stock price b. Current stock price $ 23.82
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 3 steps with 1 images

Blurred answer
Knowledge Booster
Stock Valuation
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, finance and related others by exploring similar questions and additional content below.
Similar questions
Recommended textbooks for you
Intermediate Financial Management (MindTap Course…
Intermediate Financial Management (MindTap Course…
Finance
ISBN:
9781337395083
Author:
Eugene F. Brigham, Phillip R. Daves
Publisher:
Cengage Learning
EBK CONTEMPORARY FINANCIAL MANAGEMENT
EBK CONTEMPORARY FINANCIAL MANAGEMENT
Finance
ISBN:
9781337514835
Author:
MOYER
Publisher:
CENGAGE LEARNING - CONSIGNMENT
Financial Management: Theory & Practice
Financial Management: Theory & Practice
Finance
ISBN:
9781337909730
Author:
Brigham
Publisher:
Cengage
Corporate Fin Focused Approach
Corporate Fin Focused Approach
Finance
ISBN:
9781285660516
Author:
EHRHARDT
Publisher:
Cengage
EBK CFIN
EBK CFIN
Finance
ISBN:
9781337671743
Author:
BESLEY
Publisher:
CENGAGE LEARNING - CONSIGNMENT
Fundamentals Of Financial Management, Concise Edi…
Fundamentals Of Financial Management, Concise Edi…
Finance
ISBN:
9781337902571
Author:
Eugene F. Brigham, Joel F. Houston
Publisher:
Cengage Learning